carboxymethyl-coenzyme A: structure given in first source
carboxymethyl-CoA : An S-alkyl-CoA having carboxymethyl as the S-alkyl component.
ID Source | ID |
---|---|
PubMed CID | 444878 |
CHEBI ID | 136808 |
SCHEMBL ID | 1370748 |
MeSH ID | M0176629 |
Synonym |
---|
coenzyme a, carboxymethyl- |
coenzyme a, s-(carboxymethyl)- |
carboxymethyl-coenzyme a |
carboxymethyl coenzyme *a |
s-(carboxymethyl)-coa |
CHEBI:136808 |
79955-48-9 |
s-(carboxymethyl)-coenzyme a |
carboxymethyl-coa |
SCHEMBL1370748 |
(3s,5s,9r)-1-[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-10,14-dioxo-2,4,6-trioxa-18-thia-11,15-diaza-3,5-diphosphaicosan-20-oic acid 3,5-dioxide (non-preferred name) |
Q27458857 |
DTXSID401000859 |
9-{5-o-[{[(4-{[3-({2-[(carboxymethyl)sulfanyl]ethyl}imino)-3-hydroxypropyl]imino}-3,4-dihydroxy-2,2-dimethylbutoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]-3-o-phosphonopentofuranosyl}-9h-purin-6-amine |
carboxymethyl-coa; (acyl-coa); [m+h]+; |
Role | Description |
---|---|
Brassica napus metabolite | Any plant metabolite that is produced by rapeseed (Brassica napus). |
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor | An EC 2.3.3.* (acyltransferase converting acyl to alkyl group on transfer) inhibitor that interferes with the action of citrate (Si)-synthase, EC 2.3.3.1. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
S-alkyl-CoA | An alkyl sulfide consisting of coenzyme A carrying an S-alkyl substituent. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.50) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |